Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Patient Advocate Foundation launches TotalAssist, nation's largest and most comprehensive charitable patient assistance program

Patient Advocate Foundation (PRNewsfoto/Patient Advocate Foundation)

News provided by

Patient Advocate Foundation

Jul 01, 2026, 14:09 ET

Share this article

Share toX

Share this article

Share toX

Program includes nearly 150 financial assistance funds

HAMPTON, Va., July 1, 2026 /PRNewswire/ -- Today, Patient Advocate Foundation, following the March 3 announcement of a strategic merger with PAN Foundation, has launched TotalAssist, combining the strengths of both organizations to create a single, unified financial assistance program. TotalAssist is designed to remove barriers for underinsured patients to help them start treatment and remain compliant with their prescribed treatment regimen.

Continue Reading
TotalAssist
TotalAssist

Throughout their collective history, the organizations have granted over $7 billion in financial assistance to 3.8 million patients for their critical treatment costs. At a time when healthcare costs continue to rise and more people are struggling to afford care, joining forces to launch TotalAssist is a major step forward in how patient assistance works—offering simple, flexible help that's centered on real-world patient needs.

With nearly 150 disease-specific and health equity financial assistance funds, TotalAssist supports eligible patients across a wide range of conditions—from cancer and rare diseases to chronic and complex illnesses. Through these disease-specific funds, TotalAssist helps patients pay for their eligible out-of-pocket healthcare costs, including:

  • Medication, copays, coinsurance, and deductibles
  • Health insurance premiums
  • Office visit charges the day of treatment
  • Administration charges related to treatment

"The launch of TotalAssist reinforces our ongoing commitment to supporting underinsured patients as they navigate, access, and afford their care at every step of their journey, while we also work to improve the healthcare system for those who need it most," said Kevin L. Hagan, CEO of Patient Advocate Foundation. "By simplifying the patient experience and creating the nation's largest and most comprehensive charitable patient assistance program, we are ensuring even more patients start and stay on the treatments they need."

How TotalAssist works

As a patient financial assistance program, individuals who meet TotalAssist's eligibility criteria can receive grants to help cover their eligible out-of-pocket healthcare expenses, if funding is available. TotalAssist grants are charitable funding awarded to individuals, not a loan or discount program, and are offered on an individual 12-month rolling grant cycle.

TotalAssist provides help to individuals based on a patient's diagnosis, income level, insurance status, and other fund-specific eligibility criteria—not based on medications. After confirming that a disease fund offered through TotalAssist is open and eligibility criteria is met, individuals can apply for a grant online through a secure portal or by phone with a TotalAssist specialist. Once approved, a TotalAssist grant can be used right away for covered expenses, including expenses incurred during the previous six months (dependent on diagnosis date).

TotalAssist funds and eligibility criteria

As of launch, TotalAssist offers nearly 150 disease-specific, health equity, and non-disease support services funds, ranging from chronic and rare diseases to cancer and complex illnesses. Assistance amounts vary by fund, but TotalAssist's guaranteed grant model is designed to cover 100% of out-of-pocket costs for most patients within each covered disease. Funds are determined based on an independent, rigorous research process, including the demonstrated patient need evidenced in Patient Advocate Foundation's case management data—the only program in the space that can do so. TotalAssist disease funds are defined in accordance with widely recognized clinical standards, specifically using ICD-10 codes to specify the clinical scope and to support the definition of a widely recognized disease state.

Health equity funds

TotalAssist's more than 20 health equity funds were developed to direct assistance to specific populations and places experiencing intense social and financial needs. Patient Advocate Foundation developed a methodology using the ATSDR's Social Vulnerability Index and Centers for Disease Control and Prevention (CDC) Disease Incidence Data, which identified 226 counties across 36 states with the highest rates of social vulnerability and high rates of multiple chronic diseases.

Patients are automatically screened for eligibility for a health equity fund during the application process, using the zip code of the patient's home address. All other eligibility requirements and fund operations, including grant amounts, are the same as our general funds.

Non-disease and support services funds

In addition to disease-specific and health equity funds, TotalAssist also offers four non-disease and support services funds. These funds include cancer genetic and genomic testing, social needs assessment and intervention, transportation, and virology testing health equity. Patients can enroll in disease fund(s) and non-disease and support services funds concurrently.

TotalAssist eligibility criteria

Although specific eligibility criteria vary by fund, general eligibility requirements include:

  • Have a confirmed diagnosis of the disease or condition supported by the fund. (Diagnosis is verified for all applications.)
  • Be in treatment (including active surveillance), planning to begin treatment in the next 60 days, or have been in treatment within the past 6 months.
  • Have the specified health insurance that covers qualifying expenses.
  • Have an income that falls at or below the indicated level of the Federal Poverty Level. (500% or less for most funds. Adjusted for Cost of Living Index [COLI] and number of people in the household.)
  • Be a legal resident of and receive treatment in the U.S. or a U.S. territory.
  • Be prescribed a medication or product that is listed on the approved medication list for that disease. (If using your grant for medication copays, coinsurance, or deductibles.)

What this means for patients

In addition to providing more comprehensive coverage, TotalAssist also offers patients more flexibility and a simplified patient experience. Some key benefits for patients, and their stakeholders, include:

  • Comprehensive coverage. TotalAssist is designed to provide broad, consistent support across all funds.
  • Flexible use of funds. Those who receive a TotalAssist grant may use it for any combination of eligible expenses, not limited to just one category.
  • First-come, first-served enrollments. No waitlists, with instant eligibility decisions made at the time of application, in most cases.
  • TotalAssist Fund Notification System. Anyone can sign up for free at TotalAssist.org/notify to receive notifications via email, text (SMS), and/or automated phone call when a TotalAssist fund opens for applications.
  • Seamless and secure self-service portals. TotalAssist offers separate online portals for patients, providers, pharmacies, and nonprofits that are available 24/7.
  • Six-month lookback coverage. Financial assistance can be applied to expenses incurred up to six months prior to enrollment and dependent on diagnosis date.
  • Approved disease-specific medication lists. Includes all products that are FDA-approved, listed in official compendia, or included in published evidence-based or clinical guidelines.
  • Simple diagnosis verification. Providers and pharmacies verify diagnosis during the application process. TotalAssist handles this process for patients, faxing the required verification form to the physician office.
  • Guaranteed grant amounts. Anyone who is approved for a TotalAssist grant will receive a minimum guaranteed award amount per fund. Patients who need additional funding during their original 12-month grant cycle may receive more automatically, based on availability of funding.
  • Enrollment in multiple funds. Patients can enroll in more than one TotalAssist grant, as long as they meet each fund's eligibility guidelines.

"We designed TotalAssist with the needs of real-world patients in mind," said Fran Castellow, MSEd, President of Operations at Patient Advocate Foundation. "By allowing patients to apply their TotalAssist grant toward multiple healthcare expenses—and empowering them to decide how they use their grant—we're helping to reduce gaps in care and meeting patients where they are. Because at the end of the day, when someone is facing a serious or life-threatening diagnosis, they shouldn't be faced with the added stress of how they're going to afford their care."

To learn more about TotalAssist and to see which funds may be accepting applications, visit TotalAssist.org.

About Patient Advocate Foundation

Patient Advocate Foundation is the nation's most comprehensive nonprofit dedicated to helping patients navigate, access, and afford their care while improving the healthcare system for all. We provide financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health.

Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped more than 3.8 million people access and navigate care, granted over $7 billion in financial assistance, provided personalized case management support to over 350,000 patients, and elevated the patient's voice to drive improvements in the healthcare system.

Learn more at Uniting.PatientAdvocate.org.

Media contact: Liz Eckert, [email protected]

SOURCE Patient Advocate Foundation

21%

more press release views with 
Request a Demo

Modal title

Also from this source

New national survey reveals gap between primary care provider support for clinical trials and real-world patient access

New national survey reveals gap between primary care provider support for clinical trials and real-world patient access

Despite overwhelming support for clinical trials among primary care providers (PCPs), a new national survey from Patient Advocate Foundation (who...

Patient Advocate Foundation and PAN Foundation Announce Merger to Create Nation's Most Comprehensive Nonprofit Dedicated to Helping Patients Navigate, Access, and Afford Care

Patient Advocate Foundation and PAN Foundation Announce Merger to Create Nation's Most Comprehensive Nonprofit Dedicated to Helping Patients Navigate, Access, and Afford Care

Patient Advocate Foundation and PAN Foundation today announced a strategic merger to create the nation's most comprehensive nonprofit dedicated to...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

New Products & Services

New Products & Services

Not For Profit

Not For Profit

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.